Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 290.64B, Merck(MRK) trades at $116.70. The stock has a price-to-earnings ratio of 16.16 and currently yields dividends of 2.8%.
As of 2026-02-11, Merck(MRK) stock has fluctuated between $116.10 and $118.16. The current price stands at $116.70, placing the stock +0.5% above today's low and -1.2% off the high.
The Merck(MRK)'s current trading volume is 11.85M, compared to an average daily volume of 17.1M.
In the last year, Merck(MRK) shares hit a 52-week high of $122.66 and a 52-week low of $73.31.
In the last year, Merck(MRK) shares hit a 52-week high of $122.66 and a 52-week low of $73.31.
MRK News
New insider activity at Merck & Company ( (MRK) ) has taken place on February 10, 2026. Executive VP & President, MRL, Dean Y. Li has executed a notable inside...
The Food and Drug Administration approved pembrolizumab, Keytruda from Merck (MRK), as well as pembrolizumab and berahyaluronidase alfa-pmph or Keytruda Qlex fr...
Merck (NYSE:MRK) has entered a collaboration with Calla Lily Clinical Care to develop a novel intravaginal drug delivery platform using the Callavid device. He...
Analyst ratings
57%
of 28 ratingsMore MRK News
The biotech has momentum as its quarterly report approaches. Moderna (MRNA +2.24%) has been on fire this year, with the biotech's shares up by 39% through Feb....
In early February 2026, Merck reported full-year 2025 sales of US$65.01 billion and earnings per share of US$7.28, issued 2026 sales guidance of US$65.5–67.0 bi...
Advertisement Why Health Canada’s Enflonsia approval matters for Merck (MRK) Merck (MRK) just picked up Health Canada approval for Enflonsia, an RSV monoclona...
Health Canada has approved Merck's ENFLONSIA (clesrovimab), a monoclonal antibody for the prevention of respiratory syncytial virus (RSV) in newborns and infant...
New insider activity at Merck & Company ( (MRK) ) has taken place on February 6, 2026. Multiple top executives at Merck & Company have recently executed sizabl...
Merck reported significant pipeline progress and new product launches as it prepares for the eventual loss of Keytruda exclusivity. The company expanded its po...
Goldman Sachs analyst Asad Haider raised the firm’s price target on Merck (MRK) to $133 from $120 and keeps a Buy rating on the shares. Merck shares rose 2.2% d...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.